Orencia remission Induction and Outcome Navigation Study
Phase 4
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000004137
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are inadequate by investigator 's decision
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of the discontinuation of abatacept at one year after discontinuation of abatacept
- Secondary Outcome Measures
Name Time Method 1) Change in remission rate (DAS28-CRP) 2) X ray 3) Change in HAQ 4) The mean of re-administration time 5) Stratified analysis of remission conditions 6) Efficacy and safety of re-administration of abatacept after recurrence